Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
SYRE	SPYRE THERAPEUTICS INC	$7.47B	-24.30%	-22.20%	-16.12%	-28.00%	0.07	18.53	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$20.80M	-618.90%	-100.70%	-802.91%	538.50%	7.35	1.48	N/A	N/A	N/A
QNTM	QUANTUM BIOPHARMA LTD	$28.94M	-417.20%	-184.20%	-409.47%	2,152.90%	1.04	1.20	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$11.47M	N/A	-181.30%	-14.68%	91.70%	0.15	7.99	-25.00%	-11,314.10%	-1,782.22%
VYGR	VOYAGER THERAPEUTICS INC	$162.67M	-57.90%	-45.00%	-59.43%	-53.80%	0.28	7.51	100.00%	-312.60%	-312.26%
KARD	KARDIGAN INC	$1.37B	N/A	N/A	N/A	N/A	0.17	8.72	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$754.02M	-38.40%	-34.70%	-17.36%	-1,845.60%	0.05	25.13	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$800.49M	-41.30%	-35.90%	-40.27%	-42.80%	0.21	8.03	100.00%	-194.70%	-194.74%
KLRA	KAILERA THERAPEUTICS INC	$1.42B	N/A	N/A	N/A	N/A	0.08	11.11	N/A	N/A	N/A
ALMS	ALUMIS INC	$943.58M	-103.00%	-82.30%	-90.98%	-113.90%	0.24	6.74	100.00%	-5,933.50%	-5,957.20%
RLAY	RELAY THERAPEUTICS INC	$4.02B	-42.30%	-38.70%	-31.20%	-46.90%	0.09	18.27	100.00%	-2,763.60%	-2,763.64%
OSTX	OS THERAPIES INC	$74.26M	N/A	-477.40%	365.68%	326.00%	-1.74	0.18	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$340.11M	-28.40%	-27.80%	-25.69%	7,762.40%	0.03	34.00	N/A	N/A	N/A
BNTX	BIONTECH SE	$24.93B	-9.10%	-8.00%	-8.60%	-18.40%	0.15	7.85	75.50%	-63.60%	-59.68%
ABCL	ABCELLERA BIOLOGICS INC	$4.54B	-17.50%	-12.40%	-15.97%	-16.80%	0.46	12.77	100.00%	-248.80%	-302.80%
IBIO	IBIO INC	$75.24M	-47.90%	-42.20%	-37.76%	-112.80%	0.16	7.85	100.00%	-33,044.00%	-32,991.00%
VERU	VERU INC	$43.65M	-45.90%	-34.60%	-44.08%	-365.60%	0.31	4.42	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$2.08M	-519.10%	-194.60%	-246.52%	388.90%	0.29	3.00	N/A	N/A	N/A
AGMB	AGOMAB THERAPEUTICS NV	$513.20M	N/A	N/A	N/A	N/A	0.10	12.88	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$980.12M	-53.10%	-48.30%	-63.34%	-67.30%	0.13	8.42	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$1.67B	-59.40%	-51.50%	-63.39%	-89.30%	0.14	7.69	100.00%	-753.60%	-808.90%
AMLX	AMYLYX PHARMACEUTICALS INC	$3.26B	-52.90%	-48.50%	-62.46%	-133.20%	0.11	12.12	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$599.22M	-39.90%	-31.50%	-23.27%	-39.50%	0.26	9.36	100.00%	-451.60%	-433.95%
GOSS	GOSSAMER BIO INC	$70.76M	N/A	-85.40%	187.72%	-58.40%	-1.82	0.53	100.00%	-235.00%	-214.60%
BHVN	BIOHAVEN LTD	$2.01B	-1,328.90%	-138.30%	-190.08%	-155.20%	29.33	4.73	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$16.47M	-346.20%	-178.40%	-1,465.67%	470.00%	4.26	1.25	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$577.72M	-31.40%	-27.00%	-17.14%	-30.40%	0.11	26.78	100.00%	-296,000.00%	-284,593.55%
QNCX	QUINCE THERAPEUTICS INC	$31.70M	N/A	-104.50%	-81.94%	-1,714.50%	-0.44	14.52	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$1.40B	-138.10%	-81.70%	-107.57%	-125.50%	2.05	11.09	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$82.77M	-1,625.90%	-101.30%	-159.50%	-130.10%	-50.24	3.15	N/A	N/A	N/A
CDT	CDT EQUITY INC	$45.63k	-72.30%	-55.40%	-35.79%	-72.40%	0.23	0.13	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$48.36M	-1,266.40%	-139.90%	-163.87%	-252.00%	2.95	2.77	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$295.07M	-41.70%	-30.40%	-48.47%	-56.20%	0.40	6.64	67.10%	-246.40%	-293.83%
PYXS	PYXIS ONCOLOGY INC	$241.88M	-215.20%	-112.20%	-319.24%	-141.10%	3.80	1.34	78.40%	-803.80%	-793.84%
ABOS	ACUMEN PHARMACEUTICALS INC	$162.35M	-136.30%	-81.60%	-145.64%	-135.20%	1.03	2.47	N/A	N/A	N/A
CADL	CANDEL THERAPEUTICS INC	$832.52M	-89.40%	-56.30%	-42.88%	-240.10%	0.65	16.09	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$69.95M	-211.10%	-126.30%	-122.12%	430.90%	0.37	4.51	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$5.73B	-273.20%	-85.50%	-118.60%	-99.80%	3.20	2.49	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$267.20M	-27.20%	-25.70%	-29.53%	-57.40%	0.06	19.47	N/A	N/A	N/A
NMAD	NOMAD POWER SOLUTIONS INC	$60.38M	-75.10%	-62.70%	-34.30%	-113.60%	0.07	12.87	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$5.82B	-160.20%	-87.20%	-88.17%	-209.20%	1.06	7.02	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$282.30M	-28.50%	-27.20%	-27.10%	-38.50%	0.04	31.35	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$423.01M	-81.90%	-63.70%	-76.56%	-84.80%	0.33	9.06	N/A	N/A	N/A
QURE	UNIQURE NV	$1.70B	-112.00%	-29.00%	-20.57%	-19.90%	2.04	10.01	92.50%	-1,350.70%	-993.35%
RVMD	REVOLUTION MEDICINES INC	$43.83B	-96.40%	-63.20%	-43.06%	-66.30%	0.66	11.38	N/A	N/A	N/A
KRSA	KORSANA BIOSCIENCES INC	$22.74M	-88.00%	-74.90%	-131.85%	-145.20%	0.36	0.82	100.00%	-353.00%	-353.00%
CLDX	CELLDEX THERAPEUTICS INC	$2.48B	-52.40%	-47.60%	-41.68%	-58.10%	0.10	11.82	100.00%	-190,220.90%	-190,220.89%
ORKA	ORUKA THERAPEUTICS INC	$5.44B	-20.80%	-20.10%	-11.90%	-25.10%	0.02	38.51	N/A	N/A	N/A
FRMM	FORUM MARKETS INC	$63.75M	-218.40%	-127.30%	-345.50%	-133.90%	0.24	2.69	91.00%	-4,971.70%	-4,931.88%
REPL	REPLIMUNE GROUP INC	$1.22B	-159.30%	-90.80%	-134.38%	-134.10%	1.39	5.23	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$437.57M	-256.70%	-69.60%	-110.26%	-54.50%	18.94	3.48	71.40%	-184.20%	-177.88%
EVMN	EVOMMUNE INC	$303.04M	-62.60%	-40.50%	-33.28%	-53.20%	0.09	11.68	100.00%	-946.70%	-946.68%
ALDX	ALDEYRA THERAPEUTICS INC	$79.63M	-53.10%	-34.90%	-57.10%	452.20%	0.26	4.91	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$1.50B	-34.90%	-30.20%	-25.91%	-56.10%	0.17	18.31	100.00%	-667.90%	-658.97%
CTNM	CONTINEUM THERAPEUTICS INC	$432.64M	-24.70%	-23.50%	-23.60%	-27.90%	0.05	37.17	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$35.50M	-155.10%	-130.60%	-134.00%	-411.10%	0.16	7.07	N/A	N/A	N/A
ENGN	ENGENE THERAPEUTICS INC	$130.68M	-55.80%	-45.20%	-48.94%	-49.90%	0.25	10.21	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$91.02M	-103.10%	-75.60%	-150.95%	-141.30%	0.41	3.30	100.00%	-7,889.00%	-7,884.06%
SABS	SAB BIOTHERAPEUTICS INC	$292.98M	-6.70%	-6.10%	-5.54%	-6.60%	0.11	9.22	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$126.42M	N/A	-126.90%	-7,809.79%	89.60%	-201.94	0.86	46.60%	-691.80%	-658.10%
ORIC	ORIC PHARMACEUTICALS INC	$1.39B	-35.40%	-33.40%	-36.56%	-39.70%	0.06	13.19	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$127.39M	-242.30%	-131.30%	-211.61%	-597.70%	1.81	4.50	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$335.70M	-128.30%	-95.50%	-82.57%	-353.60%	0.22	5.79	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$989.26M	-36.10%	-33.60%	-23.99%	-40.30%	0.06	16.16	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$189.70M	-41.70%	-38.80%	-43.01%	-46.80%	0.09	10.97	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$326.19M	-137.40%	-97.70%	-131.62%	-823.00%	0.30	4.70	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$5.49B	-72.60%	-48.70%	-47.98%	-53.60%	0.57	13.57	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$543.76M	-45.60%	-43.30%	-38.20%	-123.80%	0.08	16.00	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$1.46B	-50.30%	-46.70%	-44.63%	-70.50%	0.08	14.16	N/A	N/A	N/A
CDXS	CODEXIS INC	$147.83M	-74.40%	-23.60%	-26.07%	-17.70%	2.64	3.06	87.00%	-39.60%	-32.41%
TSHA	TAYSHA GENE THERAPIES INC	$1.63B	-56.20%	-41.80%	-33.66%	-260.20%	0.22	17.77	100.00%	-2,728.00%	-2,727.27%
SGMT	SAGIMET BIOSCIENCES INC	$579.94M	-32.00%	-30.60%	-18.25%	-58.30%	0.03	45.03	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$27.33M	N/A	-200.90%	765.61%	-102.00%	-1.34	0.79	95.90%	-153.30%	-119.66%
PCVX	VAXCYTE INC	$8.44B	-37.60%	-33.60%	-37.12%	-37.80%	0.14	5.72	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$637.78M	-73.20%	-62.00%	-39.85%	-90.70%	0.10	16.82	N/A	N/A	N/A
NBP	NOVABRIDGE BIOSCIENCES	$159.00M	-37.90%	-34.40%	-36.71%	-265.40%	0.15	7.64	N/A	N/A	N/A
LXRX	LEXICON PHARMACEUTICALS INC	$836.52M	-40.40%	-26.90%	-22.41%	-33.70%	0.43	13.37	99.10%	-147.40%	-127.16%
ZURA	ZURA BIO LTD	$383.32M	-74.70%	-66.50%	-43.12%	752.30%	0.08	12.90	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$6.91B	-69.60%	-62.50%	-73.28%	1,761.00%	0.16	7.27	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$10.25M	-875.70%	-149.70%	-256.91%	610.40%	0.82	0.94	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$465.75M	-147.20%	-103.20%	-98.22%	3,983.00%	1.68	8.98	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$767.73M	-72.30%	-61.40%	-52.85%	-114.30%	0.12	13.82	N/A	N/A	N/A
PVLA	PALVELLA THERAPEUTICS INC	$2.00B	-47.80%	-38.30%	-21.80%	-242.00%	0.17	21.18	N/A	N/A	N/A
LBRX	LB PHARMACEUTICALS INC	$1.20B	-25.90%	-24.70%	-25.34%	-149.20%	0.09	15.08	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$280.60M	-41.90%	-38.00%	-36.45%	-57.90%	0.08	13.89	N/A	N/A	N/A
PHVS	PHARVARIS NV	$2.23B	-61.00%	-55.60%	N/A	-1,530.20%	0.09	N/A	N/A	N/A	N/A
NGNE	NEUROGENE INC	$568.12M	-45.10%	-41.00%	-49.86%	-69.80%	0.13	10.65	N/A	N/A	N/A
MDWD	MEDIWOUND LTD	$178.16M	-47.20%	-24.30%	-40.25%	-53.50%	1.02	2.32	15.50%	-170.10%	-180.95%
LTRN	LANTERN PHARMA INC	$13.87M	-456.40%	-184.30%	-435.83%	27,389.90%	-3.67	1.96	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$10.90M	N/A	-495.60%	-241.16%	3,653.60%	-0.75	5.63	N/A	N/A	N/A
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$85.59M	N/A	-1,220.50%	239.87%	330.60%	-1.28	0.18	N/A	N/A	N/A
RZLT	REZOLUTE INC	$395.59M	-63.00%	-57.90%	-76.49%	-67.70%	0.12	9.68	N/A	N/A	N/A
ABVX	ABIVAX SA	$7.85B	-91.10%	-71.50%	-64.02%	-2,522.40%	0.26	5.97	100.00%	-7,979.70%	-4,972.24%
IKT	INHIBIKASE THERAPEUTICS INC	$281.86M	-42.80%	-40.60%	-39.55%	-78.60%	0.07	15.82	N/A	N/A	N/A
QCLS	Q/C TECHNOLOGIES INC	$7.31M	-100.70%	-52.60%	-85.83%	-245.20%	0.24	3.29	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$255.47M	-33.20%	-27.80%	-33.72%	-351.60%	0.19	12.08	100.00%	-311.10%	-307.96%
SANA	SANA BIOTECHNOLOGY INC	$871.14M	-134.50%	-51.10%	-68.82%	-165.80%	1.79	1.38	N/A	N/A	N/A
VRCA	VERRICA PHARMACEUTICALS INC	$76.62M	-444.40%	-76.60%	-202.22%	-301.60%	7.36	1.45	85.90%	-102.80%	-90.53%
EDSA	EDESA BIOTECH INC	$34.32M	-124.20%	-105.70%	-160.04%	1,020.90%	0.44	2.76	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$1.23B	-41.50%	-38.60%	-39.50%	-66.90%	0.09	11.59	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.